Lipoprotein(a), Chlamydia pneumoniae, leptin and tissue plasminogen activator as risk markers for valvular aortic stenosis von Glader, C.A, Birgander, L.S, Söderberg, S, Ildgruben, H.P, Saikku, P, Waldenström, A, Dahlén, G.H

Volltext

The proatherogenic properties of lipoprotein(a) may be enhanced through the formation of circulating immune complexes containing Chlamydia pneumoniae -specific IgG antibodies von Glader, C.A, Boman, J, Saikku, P, Stenlund, H, Weinehall, L, Hallmanns, G, Dahlén, G.H

Volltext

A high lipoprotein(a) level may be a riskfactor for valvular aortic stenosis in the elderly von Ahlbeck Glader, C., Slunga Birgander, L., Waldenström, A., Dahlén, G.H.

Volltext

2.P.107 The importance of Lp(a) as a risk factor for coronary heart disease in black and white US women von Dahlén, G.H., Srinivasan, S.R., Stenlund, H., Wattigney, W.A., Wall, S., Berenson, G.S.

Volltext

Lp(a) LIPOPROTEIN AND HLA-DR GENOTYPE IN EARLY CORONARY ARTERY DISEASE von Dahlén, G.H., Slunga, L., Holmlund, G., Langö, A., Lindblom, B.

Volltext

Effects of diet and eating habits on the fibrinolytic system von Sundell, I.B., Dahlén, G.H., Rånby, M.

Volltext

325 Lipoprotein(a): in vitro effects on tPA mediated fibrinolysis von Brändström, A., Dahlén, G.H., Rånby, M.

Volltext